Case study
Empowering CDMOs: A Critical Tech Transfer Rescue
Intro
When a partner’s therapy process failed after transferring to a new CDMO, our Senior Field Applications Scientist Megan Embrey quickly arrived onsite to diagnose and fix the issue. Within days, we helped restore production and provided operator training, ensuring critical treatments reached patients in time. This case underscores our unwavering commitment: we step in wherever needed, resolve complex challenges fast, and help partners maintain momentum for life-changing therapies.
Related Resources
Learn how MaxCyte's field applications scientists accelerate preclinical development for our cell therapy partners, ensuring that life-saving therapies reach patients when needed.
Why Partner with MaxCyte
Our partnership model is designed to guide you seamlessly through each phase from discovery to commercialization, offering scalable solutions, regulatory expertise, and operational support tailored to your needs.
Ready to learn how we can simplify your cell therapy manufacturing?
Contact our Business Development team Today
